Pharmaceutical compositions comprising azd9291

The present invention relates to pharmaceutical compositions suitable for oral administration, and more particularly to pharmaceutical compositions, including pharmaceutical tablet compositions, containing N-(2-{ 2-dimethylaminoethyl- methylamino} -4-methoxy-5-{ [4-(1-methylindol-3-yl)pyrimidin-2-yl...

Full description

Saved in:
Bibliographic Details
Main Authors Finnie Cindy, Raw Steven Anthony, Wilson David
Format Patent
LanguageEnglish
Published 27.10.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to pharmaceutical compositions suitable for oral administration, and more particularly to pharmaceutical compositions, including pharmaceutical tablet compositions, containing N-(2-{ 2-dimethylaminoethyl- methylamino} -4-methoxy-5-{ [4-(1-methylindol-3-yl)pyrimidin-2-yl]amino} phenyl)prop- 2-enamide ("AZD9291") or a pharmaceutically acceptable salt thereof, wherein such compositions comprise a certain amount of microcrystalline cellulose and at least one other pharmaceutical diluent.
Bibliography:Application Number: NZ20150721298